These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10804947)

  • 1. Seroprevalence of pertussis antibodies among adolescents in Israel.
    Arav-Boger R; Ashkenazi S; Gdalevich M; Cohen D; Danon YL
    Isr Med Assoc J; 2000 Feb; 2(2):174-7. PubMed ID: 10804947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey.
    Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C
    Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway.
    Aase A; Herstad TK; Merino S; Brandsdal KT; Berdal BP; Aleksandersen EM; Aaberge IS
    Clin Vaccine Immunol; 2007 Jul; 14(7):855-62. PubMed ID: 17507542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of Bordetella pertussis antibody in children and adolescents in China.
    Wang CQ; Zhu QR
    Pediatr Infect Dis J; 2011 Jul; 30(7):593-6. PubMed ID: 21422963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of antibodies to pertussis and diphtheria among healthy adults in China.
    Zhang Q; Han F; Nie Q; Ren H; Zhang B; Liu Q; He Q; Shao Z
    J Infect; 2011 Dec; 63(6):441-6. PubMed ID: 21864569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).
    Ward JI; Cherry JD; Chang SJ; Partridge S; Keitel W; Edwards K; Lee M; Treanor J; Greenberg DP; Barenkamp S; Bernstein DI; Edelman R;
    Clin Infect Dis; 2006 Jul; 43(2):151-7. PubMed ID: 16779740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of pertussis in persons < or =15 years of age in Valencia, Spain: seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents and adults.
    Diez-Domingo J; Ballester A; Baldó JM; Planelles MV; Villarroya JV; Alvarez T; Carmen Peidró M; Calero P; Garcés MD; Sorribes I; Graullera M; Jubert A; San-Martín M; González A
    J Infect; 2004 Oct; 49(3):242-7. PubMed ID: 15337342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The seroepidemiology of Bordetella pertussis in Israel--Estimate of incidence of infection.
    Rendi-Wagner P; Tobias J; Moerman L; Goren S; Bassal R; Green M; Cohen D
    Vaccine; 2010 Apr; 28(19):3285-90. PubMed ID: 20226250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative seroepidemiology of pertussis, diphtheria and poliovirus antibodies in Singapore: waning pertussis immunity in a highly immunized population and the need for adolescent booster doses.
    Lai FY; Thoon KC; Ang LW; Tey SH; Heng D; Cutter JL; Phoon MC; Chow VT
    Vaccine; 2012 May; 30(24):3566-71. PubMed ID: 22475863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
    Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
    APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pertussis seroprevalence and vaccination status in three selected provinces of Turkey].
    Kurtoğlu D; Gözalan A; Cöplü N; Miyamura K; Ishida S; Morita M; Akin L; Esen B
    Mikrobiyol Bul; 2008 Jul; 42(3):389-98. PubMed ID: 18822881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population.
    Knuf M; Zepp F; Meyer C; Grzegowski E; Wolter J; Riffelmann M; Wirsing von König CH
    Vaccine; 2006 Mar; 24(12):2043-8. PubMed ID: 16356597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adults.
    Cherry JD; Chang SJ; Klein D; Lee M; Barenkamp S; Bernstein D; Edelman R; Decker MD; Greenberg DP; Keitel W; Treanor J; Ward JI
    Clin Infect Dis; 2004 Dec; 39(11):1715-8. PubMed ID: 15578376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization status of Iranian military recruits against Bordetella pertussis infection (whooping cough).
    Izadi M; Afsharpaiman S; Jonaidi Jafari N; Ranjbar R; Gooya MM; Robat Sarpooshi J; Esfahani AA; Soheylipoor H
    J Infect Dev Ctries; 2011 Mar; 5(3):224-6. PubMed ID: 21444992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.
    Hendrikx LH; Berbers GA; Veenhoven RH; Sanders EA; Buisman AM
    Vaccine; 2009 Nov; 27(47):6530-6. PubMed ID: 19729085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of Bordetella pertussis immunoglobulin G antibodies among children in Samsun, Turkey.
    Ozkal A; Sensoy G; Acuner C; Belet N; Güney AK
    Turk J Pediatr; 2012; 54(1):15-9. PubMed ID: 22397036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of antibody titers against Bordetella pertussis in an adult population with prolonged cough.
    Kapaskelis AM; Vouloumanou EK; Rafailidis PI; Hatzopoulou P; Nikita D; Falagas ME
    Respir Med; 2008 Nov; 102(11):1586-91. PubMed ID: 18684605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of IgG antibodies to pertussis toxin in children and adolescents in Estonia.
    Jõgi P; Oona M; Toompere K; Leedo S; Epstein J; Lutsar I
    Vaccine; 2014 Sep; 32(41):5311-5. PubMed ID: 25093282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to pertussis 5 years after booster immunization during adolescence.
    Edelman K; He Q; Mäkinen J; Sahlberg A; Haanperä M; Schuerman L; Wolter J; Mertsola J
    Clin Infect Dis; 2007 May; 44(10):1271-7. PubMed ID: 17443462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria.
    Rendi-Wagner P; Paulke-Korinek M; Stanek G; Khanakah G; Kollaritsch H
    Pediatr Infect Dis J; 2007 Sep; 26(9):806-10. PubMed ID: 17721375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.